Joseph P. Hagan becomes Chief Operating Officer at Regulus

He brings nearly 15 years of experience to the La Jolla, CA, US-based firm

Joseph Hagan will join Regulus Therapeutics, a California, US-based biopharmaceutical company developing medicines targeting microRNAs, on 4 January 2016.

Hagan has also been appointed Principal Financial Officer and Principal Accounting Officer.

He brings nearly 15 years of experience in leadership roles in business development and strategy in the biotechnology industry to the firm, having held positions at Orexigen Therapeutics and Amgen.

Hagan has led numerous strategic and financing transactions including the acquisitions of Immunex and Tularik and the spinout of Novantrone and Relyspa, as well as many other business development efforts.

Before joining Amgen, he spent five years in the bioengineering labs at Genzyme and Advanced Tissue Sciences. He is currently on the board of directors of Zosano Pharma, a publicly traded biotechnology company.

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical

Therapeutic nucleotides: targeting genes

While very few nucleotide drugs have thus far reached the market, a huge amount of research is underway. Dr Sarah Houlton reports from the recent TIDES conference on a few nucleotide technologies with great therapeutic potential
Ingredients

Regulus and sanofi form microRNA therapeutics alliance

The deal represents the largest microRNA therapeutics alliance to date
Pharmaceutical

High-precision temperature control solutions for the pharmaceutical industry and biotechnology, available in the UK from Labtex

Huber offers a world-renowned range of temperature control systems and associated accessories for the Pharmaceutical Industry and Biotechnology
Sustainability

Building strong foundations for a resilient and planet-friendly future

Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
Sustainability

Dickson achieves ISO 14001 certification

ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
Regulatory

The key role of IVDs in healthcare: challenges to commercialisation and access

In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and infections, provide patients with a better understanding of their ailment and how it might be managed and changed with treatment
Distribution

Tower Cold Chain launches live tracking and monitoring for pharmaceutical distribution

The upgrade allows customers to access real-time insights into shipments, facilitating the optimisation of cold chain processes
Subscribe now